SPECTRUM PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 202M shares, a 19% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 183M shares, a 18.3% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 155M shares, a 24.5% increase from 2020.
  • Spectrum Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 124M shares, a 12.5% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 202M +32.2M +19% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 183M +28.4M +18.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 188M +29.1M +18.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 176M +20.3M +13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 170M +24.4M +16.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 155M +30.5M +24.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 159M +27.8M +21.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 155M +42.6M +37.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 145M +33.6M +30.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 124M +13.8M +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 131M +20.3M +18.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 113M +2.27M +2.06% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 112M +2.23M +2.03% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 111M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 111M +7.07M +6.79% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 110M -2.27M -2.02% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 110M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 104M +20.6M +24.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 113M +34M +43.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q3 2017 83.5M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 78.6M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2014 63.4M +4.27M +7.21% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q4 2013 60.7M -3.91M -6.05% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 61.9M -3.24M -4.97% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-18
Q2 2013 59M -4.41M -6.96% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-09
Q1 2013 59.2M -6.08M -9.31% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 64.6M +6.68M +11.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 65.1M +5.67M +9.53% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 63.4M +5.12M +8.79% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 65.3M +9.73M +17.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 58M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 59.5M +9.73M +19.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 58.3M +9.25M +18.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 55.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-27
Q3 2010 49.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 49M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.